Jim Simons Alpine Immune Sciences, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$17.75 - $41.6 $502,254 - $1.18 Million	28,296 Added 13.06%	244,981 $9.71 Million
Q4 2023 Feb 13, 2024	SELL	$8.54 - $20.22 $610,686 - $1.45 Million	-71,509 Reduced 24.81%	216,685 $4.13 Million
Q3 2023 Nov 14, 2023	SELL	$10.13 - $13.98 $315,043 - $434,778	-31,100 Reduced 9.74%	288,194 $3.3 Million
Q2 2023 Aug 11, 2023	SELL	$6.84 - $11.91 $75,240 - $131,010	-11,000 Reduced 3.33%	319,294 $3.28 Million
Q1 2023 May 12, 2023	SELL	$7.0 - $8.75 $18,200 - $22,750	-2,600 Reduced 0.78%	330,294 $2.55 Million
Q4 2022 Feb 13, 2023	SELL	$5.45 - $7.35 $140,610 - $189,630	-25,800 Reduced 7.19%	332,894 $2.45 Million
Q3 2022 Nov 14, 2022	SELL	$6.89 - $9.39 $266,643 - $363,393	-38,700 Reduced 9.74%	358,694 $2.58 Million
Q2 2022 Aug 12, 2022	BUY	$6.71 - $9.52 $75,823 - $107,576	11,300 Added 2.93%	397,394 $3.38 Million
Q1 2022 May 13, 2022	SELL	$6.41 - $13.89 $1,282 - $2,778	-200 Reduced 0.05%	386,094 $3.46 Million
Q4 2021 Feb 11, 2022	SELL	$10.41 - $13.95 $96,813 - $129,735	-9,300 Reduced 2.35%	386,294 $5.35 Million
Q3 2021 Nov 12, 2021	SELL	$8.19 - $11.31 $27,846 - $38,454	-3,400 Reduced 0.85%	395,594 $4.22 Million
Q2 2021 Aug 13, 2021	BUY	$8.81 - $15.03 $18,501 - $31,563	2,100 Added 0.53%	398,994 $3.59 Million
Q1 2021 May 13, 2021	SELL	$10.02 - $13.92 $620,238 - $861,648	-61,900 Reduced 13.49%	396,894 $4.21 Million
Q4 2020 Feb 10, 2021	BUY	$7.42 - $15.96 $520,223 - $1.12 Million	70,111 Added 18.04%	458,794 $5.78 Million
Q3 2020 Nov 13, 2020	BUY	$7.15 - $11.5 $1.17 Million - $1.89 Million	164,028 Added 73.01%	388,683 $3.42 Million
Q2 2020 Aug 13, 2020	BUY	$2.77 - $12.1 $253,455 - $1.11 Million	91,500 Added 68.72%	224,655 $2.18 Million
Q1 2020 May 14, 2020	BUY	$2.15 - $4.41 $11,491 - $23,571	5,345 Added 4.18%	133,155 $383,000
Q4 2019 Feb 13, 2020	BUY	$2.45 - $3.87 $37,850 - $59,787	15,449 Added 13.75%	127,810 $491,000
Q3 2019 Nov 13, 2019	BUY	$3.5 - $5.0 $21,350 - $30,500	6,100 Added 5.74%	112,361 $445,000
Q2 2019 Aug 12, 2019	BUY	$4.08 - $7.75 $42,432 - $80,600	10,400 Added 10.85%	106,261 $447,000
Q1 2019 May 14, 2019	BUY	$4.09 - $7.19 $35,047 - $61,611	8,569 Added 9.82%	95,861 $658,000
Q4 2018 Feb 13, 2019	BUY	$3.68 - $6.07 $321,234 - $529,862	87,292 New	87,292 $321,000

Others Institutions Holding ALPN

# of Institutions

Shares Held

56.2K

Call Options Held

Put Options Held

View Full List

About ALPINE IMMUNE SCIENCES, INC.

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

More about ALPN

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account